Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Bibliographic Details
Main Authors: Yuka Shibata, Hideki Nakajima, Kimiko Nakajima, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka, Shigetoshi Sano
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Journal of Cutaneous Immunology and Allergy
Online Access:https://doi.org/10.1002/cia2.12174
id doaj-c090de91f86641428a9bec3566a15ee0
record_format Article
spelling doaj-c090de91f86641428a9bec3566a15ee02021-08-02T07:20:29ZengWileyJournal of Cutaneous Immunology and Allergy2574-45932021-08-0144878910.1002/cia2.12174Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritisYuka Shibata0Hideki Nakajima1Kimiko Nakajima2Satoshi Serada3Minoru Fujimoto4Tetsuji Naka5Shigetoshi Sano6783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japanhttps://doi.org/10.1002/cia2.12174
collection DOAJ
language English
format Article
sources DOAJ
author Yuka Shibata
Hideki Nakajima
Kimiko Nakajima
Satoshi Serada
Minoru Fujimoto
Tetsuji Naka
Shigetoshi Sano
spellingShingle Yuka Shibata
Hideki Nakajima
Kimiko Nakajima
Satoshi Serada
Minoru Fujimoto
Tetsuji Naka
Shigetoshi Sano
Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
Journal of Cutaneous Immunology and Allergy
author_facet Yuka Shibata
Hideki Nakajima
Kimiko Nakajima
Satoshi Serada
Minoru Fujimoto
Tetsuji Naka
Shigetoshi Sano
author_sort Yuka Shibata
title Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_short Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_full Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_fullStr Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_full_unstemmed Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_sort leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
publisher Wiley
series Journal of Cutaneous Immunology and Allergy
issn 2574-4593
publishDate 2021-08-01
url https://doi.org/10.1002/cia2.12174
work_keys_str_mv AT yukashibata leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT hidekinakajima leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT kimikonakajima leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT satoshiserada leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT minorufujimoto leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT tetsujinaka leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
AT shigetoshisano leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
_version_ 1721239490100461568

Similar Items